The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Malnutrition Is High and Underestimated During Chemotherapy in Gastrointestinal Cancer: An AGEO Prospective Cross-Sectional Multicenter Study
Abstract
Although malnutrition is known to be frequent in cancer patients, it has not been described in a selected population of patients with gastrointestinal malignancies under chemotherapy only. Physician judgment about malnutrition and risk factors for malnutrition were also evaluated. All consecutive in- and outpatients of 11 centers were prospectively enrolled in a cross-sectional 14-day period study and classified according to the French health recommendations [Haute Autorité de Santé (HAS)]. Among 313 patients enrolled in 11 centers (mean age = 63 yr; range = 21-93; 67% male) mainly with colorectal (58%), pancreatic (15%), gastric (11%), and hepatobiliary (10%) primary tumors, the prevalence of malnutrition was 52%. Moderate and severe malnutrition was present in 27% and 25% of cases, respectively. Physicians considered it in 36% and 6% of cases, respectively, thereby misclassifying 134 patients (43%). The agreement between the HAS definition and the physicians' judgment was very low (κ = 0.30). Most of the patients who were identified as severely malnourished received no nutritional support. Performance status and pancreatic and gastric cancers were independently associated with malnutrition. Malnutrition levels are high, around 50%, unequally distributed according to the primitive tumor. It is still underestimated by physicians. Weight loss remains a clinically relevant, simple, and reliable marker of malnutrition.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal Cancer
Hurwitz, H., Fehrenbacher, L., Novotny, W., Cartwright, T., Hainsworth, J., Heim, W., Berlin, J., Baron, A., Griffing, S., Holmgren, E., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032691 · Cited by 10,968
Cunningham, D., Humblet, Y., Siena, S., Khayat, D., Bleiberg, H., Santoro, A., Bets, D., Mueser, M., Harstrick, A., Verslype, C., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa033025 · Cited by 5,035 · cited 1×
“Physician evalution No 124 (40) 37 (12) 21 (7) 182 (58) Moderate 25 (8) 43 (14) 45 (14) 113 (36) Severe 1 (0) 5 (2) 12 (4) 18 (6) Total 150 (48) 85 (27) 78 (25) 313 (100)”
What is subjective global assessment of nutritional status?
Detsky, A., McLaughlin, Baker, J., Johnston, N., Whittaker, S., Mendelson, R., & Jeejeebhoy, K. (1987) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/014860718701100108 · Cited by 3,252 · cited 2×
“Colorectal 110 (60) 49 (27) 24 (13) 183 (100) Pancreatic 13 (27) 13 (27) 22 (46) 48 (100) Gastric 5 (15) 14 (41) 15 (44) 34 (100) Hepatobiliary 14 (45) 8 (26) 9 (29) 31 (100) Esophageal 8 (47) 1 (6) 8 (47) 17 (100) All 150 (48) 85 (27) 78 (25) 313 (100) D ow nl oa de d by [ U ni ve rs ity o f C al ga ry ] at 1 1: 47 1…”
ESPEN Guidelines for Nutrition Screening 2002
Kondrup, J. (2003) · Clinical Nutrition · doi:10.1016/s0261-5614(03)00098-0 · Cited by 3,159
Incidence and recognition of malnutrition in hospital
McWhirter, J. P., & Pennington, C. R. (1994) · BMJ · doi:10.1136/bmj.308.6934.945 · Cited by 1,504
Bauer, J., Capra, S., & Ferguson, M. (2002) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1601412 · Cited by 1,178 · cited 2×
“Physician evalution No 124 (40) 37 (12) 21 (7) 182 (58) Moderate 25 (8) 43 (14) 45 (14) 113 (36) Severe 1 (0) 5 (2) 12 (4) 18 (6) Total 150 (48) 85 (27) 78 (25) 313 (100)”
The German hospital malnutrition study
Pirlich, M., Schütz, T., Norman, K., Gastell, S., Lübke, H. J., Bischoff, S. C., Bolder, U., Frieling, T., Güldenzoph, H., Hahn, K., et al. (2006) · Clinical Nutrition · doi:10.1016/j.clnu.2006.03.005 · Cited by 720 · cited 1×
“Most of the published cohort studies assessing malnutrition in cancer patients mixed all types of cancer patients, showing malnutrition prevalence in around 30% (19,20), much less than the 52% of patients described in this work.”
Bozzetti, F., Braga, M., Gianotti, L., Gavazzi, C., & Mariani, L. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06578-3 · Cited by 494 · cited 1×
“This raises the controversial question of the relevance of nutritional support for cancer patients (33) Although perioperative nutrition has been shown to lower postoperative morbidity and shorten the hospital stay (34), no significant benefit in terms of survival or morbidity has been found outside the surgical setti…”
Cited by
ESPEN guidelines on nutrition in cancer patients
Arends, J., Bachmann, P., Baracos, V., Barthelemy, N., Bertz, H., Bozzetti, F., Fearon, K., Hütterer, E., Isenring, E., Kaasa, S., et al. (2017) · Clinical Nutrition · doi:10.1016/j.clnu.2016.07.015 · Cited by 3,114
ESPEN expert group recommendations for action against cancer-related malnutrition
Arends, J., Baracos, V., Bertz, H., Bozzetti, F., Calder, P. C., Deutz, N. E. P., Erickson, N., Laviano, A., Lisanti, M. P., Lobo, D. N., et al. (2017) · Clinical Nutrition · doi:10.1016/j.clnu.2017.06.017 · Cited by 1,305
Prevalence of malnutrition in patients at first medical oncology visit: the PreMiO study
Muscaritoli, M., the PreMiO Study Group, Lucia, S., Farcomeni, A., Lorusso, V., Saracino, V., Barone, C., Plastino, F., Gori, S., Magarotto, R., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.20168 · Cited by 438
Fuchs-Tarlovsky, V., Castillo Pineda, J. C., Rodríguez Veintimilla, D., Calvo Higuera, I., Grijalva Guerrero, P., Gómez García, A., Frias-Toral, E., & Santana Porbén, S. (2022) · Nutrition and Cancer · doi:10.1080/01635581.2021.2014902 · Cited by 21
Metadata
- Authors
- Attar, A., Malka, D., Sabaté, J. M., Bonnetain, F., Lecomte, T., Aparicio, T., Locher, C., Laharie, D., Ezenfis, J., & Taieb, J.
- Venue
- Nutrition and Cancer
- Publisher
- Informa UK Limited
- Published
- 2012-05
- Volume
- 64
- Issue
- 4
- Pages
- 535-542
- ISSN
- 0163-5581 (ISSN-L)
- 1532-7914
- OpenAlex
- W2119554167
- Cited by
- 159
- References
- 8
- FWCI
- 2.08
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.